Long-Term Outcome after Vitrectomy for Macular Edema with Retinal Vein Occlusion Dividing into the Occlusion Site

Table 1

Baseline characteristic and patient disposition.

Parameter	Major BRVO; ()	Macular BRVO; ()	Hemispheric RVO; ()	value
Age (years)
Mean ± SD	65.7 ± 11.6	68.8 ± 10.4	74.6 ± 8.0	0.015
Median	64	69	76
Range	51–91	54–88	56–90
Gender ()
Male	28	8	10	0.482
Female	18	10	7
Site of venous occlusion ()
Superior	34	13	10	0.489
Inferior	12	5	7
BCVA
Log MAR	0.64 ± 0.34	0.54 ± 0.23	0.65 ± 0.28	0.435
Median	20/70	20/70	20/100
Range	20/250–20/50	20/200–20/50	20/500–20/50
IOP (mmHg, mean SD)	15.5 ± 3.5	16.7 ± 4.3	15.6 ± 3.9	0.364
AXL (mm, mean ± SD)	23.61 ± 1.1	23.46 ± 1.1	23.11 ± 1.7	0.127
Lens status (%)
Phakia	42 (91%)	17 (94%)	16 (94%)	0.878
CFT (m, mean ± SD)	618 ± 209	558 ± 153	730 ± 269	0.080

BCVA: best-corrected visual acuity; IOP: intraocular pressure; AXL: axial length; CFT: central foveal thickness.